Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Telomeres and Cancer: Resolving the Paradox42
Reinventing Radiobiology in the Light of FLASH Radiotherapy38
The Bidirectional Relationship Between Cancer Epigenetics and Metabolism36
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy33
Humanized Mouse Models to Evaluate Cancer Immunotherapeutics32
Immunometabolism in the Tumor Microenvironment31
The Multifaceted Role of Regulatory T Cells in Breast Cancer30
Small-Molecule Approaches to Targeted Protein Degradation30
Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced Cancer19
Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade19
Targeting KRAS G12C with Covalent Inhibitors18
Personal Neoantigen Vaccines for the Treatment of Cancer17
Oncohistones: Hijacking the Histone Code16
Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging15
Reeling in the Zebrafish Cancer Models15
Cancer Immunotherapy and the Nectin Family14
Targeting BET Bromodomains in Cancer14
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division14
AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?14
Molecular Heterogeneity and Evolution in Breast Cancer13
Strategies for Heating Up Cold Tumors to Boost Immunotherapies13
Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer12
0.089437007904053